Navigation Links
Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
Date:5/7/2008

s

Forest Laboratories is a US-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in people's lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl-D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation; and Bystolic(TM) (nebivolol), a beta-adrenergic receptor blocking agent indicated for the treatment of hypertension. In addition to our growing product line, Forest also co-promotes the Daiichi Sankyo, Inc. product Azor(TM)* (amlodipine and olmesartan medoxomil), a calcium channel blocker and angiotensin receptor blocker combination product indicated for the treatment of hypertension. For more information, visit http://www.frx.com.

* Azor is a trademark of Daiichi Sankyo, Inc. and Campral is a registered trademark of Merck Sante s.a.s., a subsidiary of Merck KGaA, Darmstadt, Germany.

Except for the historical information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in the Forest Laboratories' Annual Report on Form 10-K, Quarterly Reports on Form 10-
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
2. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
3. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
4. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
5. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
6. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
9. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... , Oct. 30, 2014 Stryker Orthopaedics, the ... Champions Tour, is rounding out its debut year of ... Scottsdale, AZ. This marks the ... Champions Tour that the brand has activated on-site with ... educate golf fans on the importance of joint health.  ...
(Date:10/30/2014)... Oct. 30, 2014 Boston Scientific Corporation (NYSE: ... the 2014 Credit Suisse Annual Healthcare Conference on Tuesday, ... AZ.  Dan Brennan , executive vice president and ... company beginning at approximately 8:00 a.m. PT followed by ... webcast of the presentation and question and answer session ...
(Date:10/30/2014)... , Oct. 30, 2014 CVS Health (NYSE: ... new clinical affiliations with three leading regional health systems to ... The collaborating health systems include Baptist Health System in ... which include Commonwealth Health in Pennsylvania , ... Arizona , and Tennova Healthcare in Tennessee ...
Breaking Medicine Technology:Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4
(Date:10/30/2014)... Dennis Thompson HealthDay Reporter ... in Liberia -- one of three West African nations ravaged ... officials said Wednesday. Dr. Bruce Aylward, WHO,s assistant director ... burials in Liberia and no increase in laboratory-confirmed cases. He ... tame the epidemic may be making some progress, The ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Global prebiotics ... 2020, according to a new study by Grand View ... surging demand for sugar and fat free products owing ... the demand for prebiotics over the forecast period. , ... , Food & beverage was the largest application ...
(Date:10/30/2014)... The annual meeting of The ... close on Saturday, October 18th, marking the end of ... 1989. NAMS is North America’s leading non-profit organization dedicated ... all women during midlife and beyond through an understanding ... and thought leaders from fields as varied as gynecology, ...
(Date:10/30/2014)... News) -- Scientists who used stem cells to create ... could provide a new way to learn more about ... team used human pluripotent stem cells -- which can ... to grow the functional miniature stomachs, to study infection ... of ulcers and stomach cancer. The miniature stomachs ...
(Date:10/30/2014)... (HealthDay News) -- Eating a low-carb, high-fat diet could ... to new research. A review of five ... that focuses on foods like bacon, eggs, heavy cream, ... in adults whose condition doesn,t improve with medication. ... people with epilepsy whose seizures are not stopped by ...
Breaking Medicine News(10 mins):Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... homeopathic alternative for reducing the symptoms related to ... without a prescription and without negative side effects. ... use in children ages 5 to 19 released ... from the Saint Louis University School of Medicine, ...
... European Mammography Systems Product Quality Leadership Award" ... of the exceptional quality of its Computed ... quality control, product performance, quality assurance programme ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )"In addition to being a ...
... women with recurrent breast cancer, the treatment the doctor chooses ... cancer. A group from Toronto has recently completed the world,s ... biopsy of suspected tumors that recurred elsewhere in the body. ... the women having a significant change in their treatment. In ...
... Colo., March 18 Keystone Symposia on Molecular and ... first HIV/AIDS meeting in 1984 when it convenes its ... " HIV Immunobiology: From Infection to Immune Control " ... than 850 scientists from around the world will attend.These ...
... City Council for passage of life-saving legislationNEW YORK, March ... nonprofit organization dedicated to finding a cure for life-threatening ... Department of Health and Mental Hygiene (DOHMH) to create ... among restaurant workers. In addition to working with ...
... medical conditions may not see any benefit from annual prostate cancer screening tests, according to results of a... ... Click here for more information. , , ... , , , , ... , , , ...
Cached Medicine News:Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 2Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 3Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 2Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 3Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 4Health News:Research shows biopsy of recurrent breast cancer can alter treatment 2Health News:Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting 2Health News:Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting 3Health News:Food Allergy Initiative to Partner With NYC Department of Health on Educational Poster for Restaurants Citywide 2Health News:Food Allergy Initiative to Partner With NYC Department of Health on Educational Poster for Restaurants Citywide 3Health News:US trial shows no early mortality benefit from annual prostate cancer screening 2Health News:US trial shows no early mortality benefit from annual prostate cancer screening 3Health News:US trial shows no early mortality benefit from annual prostate cancer screening 4Health News:US trial shows no early mortality benefit from annual prostate cancer screening 5Health News:US trial shows no early mortality benefit from annual prostate cancer screening 6
Designed for the clockwise one-hand implantation of the Morcher Capsular Tension Ring....
...
... the OrthoPilot, physicians now have a tool ... , ,The only platform you need ... complete, cost-effective system requiring little space. Continuous ... applications make OrthoPilot a strong and trustworthy ...
... console is the heart of the Espion2 ... fanless, hard-anodized aluminum chassis, real-time DSP, USB ... channel isolated differential amplifiers. The E2 connects ... wirelessly connected over standard wi-fi Ethernet. The ...
Medicine Products: